Advertisement

Topics

Mylan's generic anticlotting drug gets tentative FDA approval

05:06 EDT 12 Jul 2019 | SmartBrief

Mylan's biosimilar to Bristol-Myers Squibb's anticlotting drug Eliquis, or apixaban, has received tentative approval from the -More

Original Article: Mylan's generic anticlotting drug gets tentative FDA approval

NEXT ARTICLE

More From BioPortfolio on "Mylan's generic anticlotting drug gets tentative FDA approval"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biosimilars
Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...